Respiratory Drug Delivery (RDD®) Europe 2019

7-10 May 2019
Estoril Congress Center, Lisbon

Respiratory Drug Delivery (RDD®) Europe 2019
connects emerging and high-level scientists, academics, industrial and
regulatory specialists, and clinicians. It is a must-attend conference
for companies involved in research, development, testing or marketing of
medicines, devices and services associated with pulmonary or nasal pharmaceutical
products. This year, RDD Europe 2019 will be held in Estoril (Lisbon),
Portugal, May 7-10, 2019, and, as in previous years is jointly organized by RDD
Online and Aptar Pharma.

The program features all new scientific
content as befits this top-rated international conference, including:

•Expert presentations during themed
sessions titled; New Approaches to Treating Old Diseases; Pipes, Particles and
Predictions: New Insights into Deposition; Re-inventing Inhalers for the
Digital Age; Take a Deep Breath: Brexit and Environmental Sustainability; and
New Approaches to Inhalation Product Development and Production.

•A Technology Exhibition, in which
excipient, device and equipment designers, component and service suppliers
present their latest developments in a tabletop format.

•Scientific Posters, covering all aspects
of regulatory science, formulation development, new research methods
and advanced drug delivery technologies. This peer-reviewed session occurs
alongside the Technology Exhibition. Accepted poster abstracts from graduate
students are automatically eligible for the VCU
RDD Peter R. Byron Graduate Student Award, which covers the winning student's
registration fee, travel expenses and accommodation up to a maximum of $2,000.

•Posters on the Podium, where particularly innovative
poster abstracts are presented in the main auditorium.

• Networking Events, which enable delegates
to maximize the benefits of attending RDD Europe 2019 by allowing time to
reflect on and discuss ideas presented at the conference while meeting new collaborators
and business partners in a range of formal and informal settings.

How to participate?

Registration is open and easy at https://www.rddonline.com/rddeurope2019.
All participants registering before January 21, 2019 benefit from a substantial
discount, as do students and employees of academic and government agencies.

All podium speakers have been invited for
RDD Europe 2019, but we welcome submission of talk titles and speaker
nominations for RDD 2020. Potential speakers with novel data and insights are
invited to submit a 200-word summary of their purpose and major findings to the
Organizing Committee (info@rddonline.com). Each summary will be reviewed for
originality, merit, and 'program fit' before invitations are issued.

The RDD Europe 2019 poster abstract
submission deadline is January 7, 2019. It is a simple online process via RDD
Online’s website: Click here to submit a Poster. Poster abstracts on all
subjects related to pulmonary and nasal medication delivery are peer-reviewed
prior to acceptance and publication.

Companies are invited to participate in the
Technology Exhibition by sponsoring a table on which components, excipients,
hardware or services may be displayed. Details and sign-up for table
sponsorship are available at https://www.rddonline.com/rddeurope2019/sponsorship.

You can find more detailed information on
the conference and the different sponsorship opportunities to maximize the
value of your participation on the conference web site https://www.rddonline.com/rddeurope2019

At INTERPHEX, find all of the State-of-the-Art Solutions you need to
Cost Effectively Develop and Manufacture Product. INTERPHEX is a premier
pharmaceutical, biotechnology, and medical device development and manufacturing
event and sponsored by Parenteral Drug Association (PDA). Dedicated to
Innovation, Technologies and Knowledge, the show focuses on the entire product
development life cycle. More info >>

One of the world’s largest contract research organizations for the
planning and conducting of clinical trials was faced with the challenge
of accommodating many different national languages on an inhaler. The
inhaler was then to be distributed in 47 countries. Due to the impressive quality and
reliable collaboration, the organization commissioned Faubel with
finding the optimal labeling solution for the inhaler.More info >>

Reading Scientific Services Ltd (RSSL), a leading provider of scientific
and technical solutions to the global biopharmaceutical,
pharmaceutical, and biopharmaceutical sectors, has introduced the United
Kingdom’s first same-day mycoplasma testing service for manufacturers
of biologic medicines.
More info >>